Victoria A. H. Fry

Characterization of a CNS penetrant, selective M₁muscarinic receptor agonist, 77‐LH‐28‐1

Christopher J. Langmead, Nigel Austin, Clive L. Branch et al. · British Journal of Pharmacology · 2008 · 131 citations · Full text

Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

Christopher J. Langmead, Victoria A. H. Fry, Ian T. Forbes et al. · Molecular Pharmacology · 2005 · 107 citations

Myelin‐induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors

Fleur Pinteaux‐Jones, Ioanna Sevastou, Victoria A. H. Fry et al. · Journal of Neurochemistry · 2008 · 70 citations · Full text

Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood–brain barrier damage

Claudie Hooper, Fleur Pinteaux‐Jones, Victoria A. H. Fry et al. · Journal of Neurochemistry · 2009 · 68 citations

Peripheral Macrophages, Immunology, Cell Death +19

SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain

David R. Thomas, Ellen M. Soffin, Claire Roberts et al. · Neuropharmacology · 2006 · 51 citations

Molecular Pharmacology, Autoreceptor Role, Molecular Neuroscience +15